KR900008813B1 - Preparation for furan derivatives - Google Patents

Preparation for furan derivatives Download PDF

Info

Publication number
KR900008813B1
KR900008813B1 KR1019880004392A KR880004392A KR900008813B1 KR 900008813 B1 KR900008813 B1 KR 900008813B1 KR 1019880004392 A KR1019880004392 A KR 1019880004392A KR 880004392 A KR880004392 A KR 880004392A KR 900008813 B1 KR900008813 B1 KR 900008813B1
Authority
KR
South Korea
Prior art keywords
formula
compound
methyl
added
hours
Prior art date
Application number
KR1019880004392A
Other languages
Korean (ko)
Other versions
KR890016032A (en
Inventor
김대황
이태호
Original Assignee
재단법인 한국화학연구소
채영복
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 재단법인 한국화학연구소, 채영복 filed Critical 재단법인 한국화학연구소
Priority to KR1019880004392A priority Critical patent/KR900008813B1/en
Publication of KR890016032A publication Critical patent/KR890016032A/en
Application granted granted Critical
Publication of KR900008813B1 publication Critical patent/KR900008813B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Furan Compounds (AREA)

Abstract

내용 없음.No content.

Description

푸란유도체의 제조방법Method for producing furan derivative

본 발명은 하기 구조식(I)의 푸란 유도체 및 그 산부가염의 새로운 제조방법에 관한 것이다.The present invention relates to a novel process for preparing furan derivatives of the following structural formula (I) and acid addition salts thereof.

Figure kpo00001
Figure kpo00001

상기 구조식의 화합물은 라니티딘으로 알려져 있으며, 위궤양 및 소화성 궤양등에 효과적인 치료제로서 널리 사용되고 있다. 상기 구조식(I)의 화합물의 제조방법에 관해서는 대한민국 특허공고 81-355, 81-356, 86-63 및 87-165등에 공지되어 있다. 이들 공지의 방법의 결점은 비등점이 낮고 유독한 티올화합물인 메틸메르캅탄까스를 다량으로 방출시키는 것이다. 이 메칠메르캅탄은 가연성이 높은 기체로서 생산 현장에서 다량으로 발생될 시에는 화재의 위험성이 매우 높을뿐만 아니라, 유독하며 이를 방지하는데에는 비용이 많이들어 경제적 및 산업적으로 문제가 많다. 이리하여 이러한 기체 티올의 방출을 감소시키는 것을 주목적으로하는 제조공정들이 특허공고 86-63, 87-165에 출원되어 있다. 그러나, 이들 방법은 메칠메르캅탄의 발생을 근원적으로 방지할 수 있는 방법이 아니므로 산업적 제반문제는 여전히 내포하고 있다. 더욱이 이들 방법들은 고가의 촉매를 사용하기도하고 또는 높은 온도에서 반응시키므로서 비등점이 5.95℃인 메칠 메르캅탄 화합물을 더욱 처리하기 어렵게하고 있을 뿐만 아니라 작업자를 보호하기 어렵게하고 있다. 또한 다량으로 발생하는 부산물을 공기중으로 날려 보내므로서 공해를 유발시키거나 아니면 고가의 비용을 들여서 폐기처분하여야 하는등 여러 가지 산업적으로나 경제적으로 결점을 지니고 있다.The compound of the above structural formula is known as ranitidine, and is widely used as an effective therapeutic agent for gastric ulcer and peptic ulcer. Methods for preparing the compound of formula (I) are known from Korean Patent Publication Nos. 81-355, 81-356, 86-63, 87-165 and the like. A drawback of these known methods is the release of a large amount of methyl mercaptankas, a low boiling point and toxic thiol compound. This methyl mercaptan is a highly flammable gas that is not only highly dangerous to fire when it is generated in a large amount at the production site, but also toxic and expensive to prevent it. Thus, manufacturing processes are disclosed in patent publications 86-63, 87-165, aiming at reducing the release of such gaseous thiols. However, these methods are not a method that can prevent the occurrence of methyl mercaptan inherently, there are still industrial problems. Moreover, these methods use expensive catalysts or react at higher temperatures, making the methyl mercaptan compound having a boiling point of 5.95 ° C. more difficult, as well as difficult to protect the operator. In addition, there are various industrial and economic drawbacks, such as causing large amounts of by-products to be blown into the air, causing pollution or disposing of them at high cost.

본 발명은 구조식(I)의 화합물을 제조하는 지금까지 알려진 방법들의 여러 가지 단점을 개선한 방법으로서 기술적으로 극히 진보된 새로운 제조방법을 제공한다.The present invention provides a novel method of preparation which is technically extremely advanced as a method of remedying various disadvantages of the known methods for preparing the compound of formula (I).

본 발명의 방법에 사용된 원료를 구조식으로 나타내자면 아래 구조식(II), (III) 및 (IV)와 같다.The raw materials used in the method of the present invention are represented by the following structural formulas (II), (III) and (IV).

본 발명의 하기 구조식(II)화합물에 구조식(III) 및 구조식(IV)의 화합물을 한 반응기내에서 차례로 반응시켜 구조식(I)의 라니티딘을 제조하는 것이다.To react the compound of formula (II) with the compound of formula (III) and formula (IV) in turn in one reactor to prepare the ranitidine of formula (I).

Figure kpo00002
Figure kpo00002

Figure kpo00003
Figure kpo00003

구조식(II)의 화합물은 기존에 알려진 화합물이지만 지금까지 구조식(II)의 화합물을 라니티딘제조에 사용한 예는 알려진 적이 없다. 뿐만 아니라 구조식(II)의 화합물에 각기 다른 두가지 아민화합물을 치환한 예도 본 발명이외에는 들어 본 적이 없다. 또한 구조식(II)와 유사한 기존에 알려진 구조식(V)의 화합물로 부터도 각기 다른 두가지 아민화합물을 차례로 치환시켜 구조식(I)과 같은 화합물을 만든 예도 본 적이 없다.The compound of formula (II) is a known compound, but there have been no known examples of the use of the compound of formula (II) in the preparation of ranitidine. In addition, examples of substituting two different amine compounds in the compound of formula (II) have not been heard other than the present invention. In addition, there has never been an example in which a compound of formula (I) has been made by substituting two different amine compounds sequentially from a compound of formula (V), which is similar to formula (II).

Figure kpo00004
Figure kpo00004

고리형태의 디티오-2-니트로메틸렌 화합물에 두가지 다른 아민화합물을 차례로 치환시키는 반응은 본 발명의 방법이 처음이다.The reaction of substituting two different amine compounds into cyclic dithio-2-nitromethylene compounds in turn is the first method of the present invention.

이와 같이 본 발명의 방법은 새로운 방법으로서 아래에 기술하는 바와 같이 여러 가지 장점을 준다. 이를 상세히 설명하자면 다음과 같다.As such, the method of the present invention is a novel method and provides several advantages as described below. This will be described in detail as follows.

종래의 방법에서는 메틸요드나 디메틸술페이트 등 유독하거나 고가의 원료를 사용하여 어렵게 중간원료에 도입시킨 메틸기를 종국에는 메틸메르캅탄까스형태로 떨어져 나가게함으로서 공해를 일으키거나 인화성이 높은 까스발생으로 인해 작업현장을 위험하게 할 뿐만 아니라 별도의 시설을 설치하여 많은 비용을 들여 폐기 처분하여야 한다.In the conventional method, a methyl group introduced into an intermediate raw material using a toxic or expensive raw material such as methyl iodine or dimethyl sulfate is finally separated into a methyl mercaptanicose form, thereby causing pollution or generating highly flammable gas. Not only does it endanger the site, but a separate facility has to be set up and disposed of at a high cost.

본 발명의 방법을 사용하면 유독하고 인화성이 높은 메틸메르캅탄까스의 발생이 전혀 없으므로 상기와 같은 제방문제가 야기되지 않을뿐만 아니라 부생물의 비등점이 높아 산업현장에서 안전하여 더욱이 반응의 부산물 조차도 유기합성 매우 유용하게 널리 사용되는 고가의 디티올 화합물로 얻어지게 되어 자원의 낭비를 없게함으로써 일거양득으로 본 발명의 방법을 더욱 가치있게 해 준다.By using the method of the present invention, there is no occurrence of toxic and highly flammable methyl mercaptan cutlet, so that not only the above embankment problem is caused, but also the byproducts of the by-product have high boiling point and are safe in the industrial field. It is obtained as an expensive dithiol compound which is very useful and widely used, thus making the method of the present invention more valuable by eliminating waste of resources.

본 발명에서는 반응의 전과정을 상온에서 수행하는 것이 또 하나의 특징이다. 가열하거나 냉각하는 일이 없으므로 에너지를 크게 절약하는 방법으로서 생산공정에서 매우 중요시 되는 점인데 본 발명의 방법은 에너지 절약적 측면에서 큰 잇점을 얻을 수 있다. 또한 본 발명에서는 1포트반응으로서 반응이 대단히 용이하게 행할수 있는 잇점도 있다. 산업적으로 큰 잇점이 되는 본 발명의 방법을 더욱 상세히 설명하면 다음과 같다.In the present invention, it is another feature that the whole process of the reaction is performed at room temperature. Since there is no heating or cooling, it is very important in the production process as a method of greatly saving energy, but the method of the present invention can obtain a great advantage in terms of energy saving. In the present invention, there is also an advantage that the reaction can be carried out very easily as a one-port reaction. The method of the present invention, which is an industrially significant advantage, is described in more detail as follows.

구조식(II)의 화합물을 구조식(III)의 화합물과 유기용매에서 함께 섞고 상온에서 교반한다. 이때 사용가능한 용매로는 메틸렌클로리드, 디클로에탄, 클로로포름, 사염화탄소,아세토니트릴, THF, 아세톤 등이며, 이와 함께 메탄올,에탄올, 이소푸로판올, n-부탄올, 2-부탄올, t-부탄올등을 적당량함께 섞어서 사용하여도 좋다.The compound of formula (II) is mixed together in the organic solvent with the compound of formula (III) and stirred at room temperature. At this time, the solvent may be methylene chloride, dichloroethane, chloroform, carbon tetrachloride, acetonitrile, THF, acetone, and the like, and methanol, ethanol, isopropanol, n-butanol, 2-butanol, t-butanol, and the like. You may mix and use together an appropriate amount.

이 반응이 완결되면 메틸아민을 가하고 상온에서 교반하면 구조식(I)의 화합물이 고수율로 생성된다. 다음 통상적인 방법으로 분리하면 구조식(I)의 화합물을 유용한 염의 형태로 얻는다. 본 발명은 다음의 실시예로서 더욱 잘 설명된다.Upon completion of this reaction, methylamine is added and stirring at room temperature yields the compound of formula (I) in high yield. Separation in the following conventional manner affords compounds of formula (I) in the form of useful salts. The invention is better illustrated by the following examples.

[실시예 1]Example 1

디클로로에탄 50ml와 t-부탄올 30ml의 혼합용매에 2-니트로메틸렌-1,3-디티안 12g과2-[[[5-(디메틸아미노)메틸-2-푸라닐]메틸]티오]에틸아민 10g을 가하고 질소대기하의 상온에서 24시간 교반한 후 40% 메틸아민 수용액 6ml를 가하고 동온도에서 5시간 더 교반한 후 감압으로 여분의 메틸아민을 제거하고 디클로로에탄 200ml를 더 가하고 100ml의 물로 3회 세척하고 용매층을 망초로 건조한다. 용매층에 c-HCI 4g정도를 가하여 물층을 pH가 4.5가 되게 한다. 물층을 분리하여 이소푸로필알콜 100ml를 적하하면서 결정의 씨를 가하고 교반하면 라니티딘 염산염 11.5g을 얻는다.Into a mixed solvent of 50 ml of dichloroethane and 30 ml of t-butanol, 12 g of 2-nitromethylene-1,3-dithiane and 10 g of 2-[[[5- (dimethylamino) methyl-2-furanyl] methyl] thio] ethylamine After stirring for 24 hours at room temperature under nitrogen atmosphere, 6 ml of 40% aqueous methylamine solution was added thereto, and further stirred at the same temperature for 5 hours, and then the excess methylamine was removed under reduced pressure, 200 ml of dichloroethane was further added, and washed three times with 100 ml of water. And the solvent layer is dried with a forget-me-not. 4 g of c-HCI is added to the solvent layer so that the water layer has a pH of 4.5. The water layer was separated, and 100 ml of isoprophyl alcohol was added dropwise, and the seed of crystal was added and stirred to obtain 11.5 g of ranitidine hydrochloride.

m.p.=139-140℃(분해)m.p. = 139-140 ° C. (decomposition)

TLC=실리카겔판/디옥산 : 메탄올 : DMF=6 : 3 : 2TLC = silica gel plate / dioxane: methanol: DMF = 6: 3: 2

Rf=0.5Rf = 0.5

[실시예 2]Example 2

1,2-디클로로에탄 250ml에 2-니트로메틸렌-1,3-디티안 60g을 녹이고 질소대기하의 25℃의 상온에서 2-[[[5-(디메틸아미노)메틸-2-푸라닐]메틸]티오]에틸아민 50g을 약 10시간에 걸쳐 천천히 적하한다음 10시간 더 교반한 후 20% 메틸아민메탈올용액 30ml를 가하여 동온도에서 6시간 더 교반한 후 감압으로 남아있는 메틸아민을 제거하고 디클로로에탄 600ml를 더 가하고 300ml의 물로 3회 세척하고 용매층을 망초로 건조한다. 유기용매층에 물 5ml를 가하고 물층이 pH=4.5가 되도록 c-HCI을 가한다음 물층을 분리하여 실시예 1과 같이 처리하면 라니티딘 염산염 59g을 얻는다.Dissolve 60 g of 2-nitromethylene-1,3-dithiane in 250 ml of 1,2-dichloroethane and give 2-[[[[5- (dimethylamino) methyl-2-furanyl] methyl] at 25 ° C under nitrogen atmosphere. 50 g of thio] ethylamine was slowly added dropwise over about 10 hours, followed by further stirring for 10 hours, and then 30 ml of 20% methylamine metallol solution was further stirred at the same temperature for 6 hours, and then the remaining methylamine was removed under reduced pressure. 600 ml of ethane is further added, washed three times with 300 ml of water and the solvent layer is dried over forget-me-not. 5 ml of water was added to the organic solvent layer, c-HCI was added so that the water layer was pH = 4.5, and the water layer was separated and treated as in Example 1 to obtain 59 g of ranitidine hydrochloride.

[실시예 3]Example 3

메틸렌클로리드 0.5ml에 2-니트로메틸렌-1,3-디티안 0.2g과 2-[[[5-(디메틸아미노)메틸-2-푸라닐]메틸]티오]에틸아민 0.14g을 가하고 질소대기하 25℃에서 20시간 교반한 후 40% 메틸아민 수용액 0.2ml를 가하고 소금을 포함한 물 5ml를 가하고 3회 세척하고 메틸렌클로리드층에 물 1ml를 가하고 d-HCI로 pH=4.5되게한 후 물층을 분리하여 TLC하여 라니티딘을 얻었다.To 0.5 ml of methylene chloride, 0.2 g of 2-nitromethylene-1,3-dithiane and 0.14 g of 2-[[[5- (dimethylamino) methyl-2-furanyl] methyl] thio] ethylamine were added, followed by nitrogen atmosphere. After stirring at 25 ° C. for 20 hours, 0.2 ml of 40% aqueous methylamine solution was added thereto, 5 ml of water including salt was added thereto, washed three times, and 1 ml of water was added to the methylene chloride layer, and then pH = 4.5 with d-HCI. TLC was isolated to give ranitidine.

[실시예 4]Example 4

1,2-디클로로에탄 0.8ml에 2-니트로메틸렌-1,3-디티안 0.4g과 2-[[[5-(디메틸아미노)메틸-2-푸라닐]메틸]티오]에틸아민 0.32g을 가하고 질소대기하의 상온에서 24시간 교반한 후 40% 메틸아민 수용액0.7ml와 메탄올 2ml를 가하고 상온에서 6시간 교반한 후 실시예 3과 같이 처리하여 산성수용액을 TLC하여 라니티딘을 얻었다.In 0.8 ml of 1,2-dichloroethane, 0.4 g of 2-nitromethylene-1,3-dithiane and 0.32 g of 2-[[[5- (dimethylamino) methyl-2-furanyl] methyl] thio] ethylamine were added. After stirring at room temperature under nitrogen atmosphere for 24 hours, 0.7 ml of 40% aqueous methylamine solution and 2 ml of methanol were added thereto, and the mixture was stirred at room temperature for 6 hours, and then treated in the same manner as in Example 3 to TLC for acidic aqueous solution to obtain ranitidine.

[실시예 5]Example 5

메틸렌클로리드 1ml에 2-니트로메틸렌-1,3-디티에판 0.2g과 2-[[[5-(디메틸아미노)메틸-2-푸라닐]메틸]티오]에틸아민 0.15g을 섞고 25℃에서 22시간 교반한 후 40% 메틸아민 수용액 0.2ml와 메탄올 0.5ml를 가하고 25℃에서 5시간 교반한 후 실시예 3과 같이 처리하고 TLC하여 라니티딘을 얻었다.To 1 ml of methylene chloride, 0.2 g of 2-nitromethylene-1,3-dithiane and 0.15 g of 2-[[[5- (dimethylamino) methyl-2-furanyl] methyl] thio] ethylamine were mixed and 25 ° C. After 22 hours of stirring at 0.2 ml of 40% aqueous methylamine solution and 0.5 ml of methanol were added thereto, and the mixture was stirred at 25 ° C. for 5 hours, followed by treatment as in Example 3, followed by TLC to obtain ranitidine.

Claims (1)

다음구조식(III)화합물 또는 그 산부가염을 다음구조식(II)의 화합물과 반응시킨 후 다음구조식(IV)의 화합물을 반응시켜서 다음구조식(I) 화합물 또는 그 산부가염을 제조하는 방법.A method for preparing the compound of formula (I) or acid addition salt thereof by reacting a compound of formula (III) or an acid addition salt thereof with a compound of formula (II) and then reacting a compound of formula (IV).
Figure kpo00005
Figure kpo00005
KR1019880004392A 1988-04-18 1988-04-18 Preparation for furan derivatives KR900008813B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019880004392A KR900008813B1 (en) 1988-04-18 1988-04-18 Preparation for furan derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019880004392A KR900008813B1 (en) 1988-04-18 1988-04-18 Preparation for furan derivatives

Publications (2)

Publication Number Publication Date
KR890016032A KR890016032A (en) 1989-11-28
KR900008813B1 true KR900008813B1 (en) 1990-11-30

Family

ID=19273698

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880004392A KR900008813B1 (en) 1988-04-18 1988-04-18 Preparation for furan derivatives

Country Status (1)

Country Link
KR (1) KR900008813B1 (en)

Also Published As

Publication number Publication date
KR890016032A (en) 1989-11-28

Similar Documents

Publication Publication Date Title
CN114805314A (en) Synthesis method of Ensaitevir
Goodfellow et al. p-Nitrophenyl 3-diazopyruvate and diazopyruvamides, a new family of photoactivatable cross-linking bioprobes
Hiskey et al. Sulfur-Containing Polypeptides. II. Selective Removal of S-Protective Groups from Some L-Cysteinyl-L-cysteine Derivatives1, 2
KR900008813B1 (en) Preparation for furan derivatives
SU1055333A3 (en) Process for preparing leurozine-type alkaloids or their acid addition salts
SU584774A3 (en) Method of preparing azoxazole derivatives
CN110204557B (en) Preparation method of cefamandole nafate derivative
CA2046293C (en) Preparation of substituted ethenes
EP0299034B1 (en) Process for the preparation of compounds with antiulcer action
KR100278119B1 (en) Manufacturing Process of Erdostain
NO145308B (en) PROCEDURE FOR THE PREPARATION OF AURANOFINE
Cook et al. 210. Studies in the azole series. Part V. A synthesis of β-phenylcysteine
SU593660A3 (en) Method of preparing derivatives of substituted a-aminooxyhydroxamic acid
IL45098A (en) Process for preparing triacetonamine
DK153481B (en) PROCEDURE FOR THE PREPARATION OF RANITIDIN
GB1522907A (en) Carbamates of 2- haloergolines and of 2- haloergolenes and process for the preparation thereof
US3308132A (en) 6, 8-dithiooctanoyl amides and intermediates
KR870000165B1 (en) Process for preparing n- (2- ((( 5-(dimethylamino)-methyl-2-furanyl)methyl)thio) ethyl-n-2-nitro-1,1-ethenediamine
NOGUCHI et al. Convenient One-pot Syntheses of Sulfinates, Sulfinamides, and Thiosulfinates by Sulfinylation with p-Toluenesulfinic Acid and Activating Reagents
US4889929A (en) Preparation of 1'-ethoxycarbonyl-oxyethyl esters of penicillins
KR910004668B1 (en) Process for the preparation of 6-demethyl-6-deoxy-6-methylene-5-oxytetracycline and 11a-chloroderivate thereof
RU2059626C1 (en) METHOD OF SYNTHESIS OF TRIS (β-DIETHYLBENZYLAMMONIO)ETHYL ESTER OF ISOCYANURIC ACID TRIBROMIDE
US4900841A (en) 1-[4-[(methyl-sulfonyl)amino]benzoyl]aziridine
JPH0219356A (en) Aminoacetonitrile derivative and production thereof
GB2033382A (en) Production of N-(4'-Chloro-3- sulphamoyl-benzenesulphonyl)-N- methyl-2-aminomethyl-2-methyl tetrahydrofuran

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
O035 Opposition [patent]: request for opposition

Free format text: OPPOSITION NUMBER: 001991000804001991000805; OPPOSITION DATE: 28171027